Creative Biosciences (Guangzhou) and DKSH Enters into a Strategic Partnership

Guangzhou, Guangdong, China, April 23, 2021—Creative Biosciences, the leading advanced bio-tech enterprise in IVD and POCT industry, announces the collaboration with DKSH Thailand, Asia’s leading partner for healthcare companies, to provide noninvasive cancer detection solution in Thai market to benefit people in reducing cancer incidence and mortality accurately and effectively.

2021-04-23

Clinical Utility of Colosafe®Is Once Again Proved Valuable！

Recently a clinical study called “A novel stool-based SDC2 DNA methylation test is more robust than FIT and plasma CEA in detecting colorectal neoplasia in China” was published on American Journal of Translational Medicine. The study compared the detection performance of Colosafe®, FIT and plasma CEA. The result evidently revealed the value and advantage of Colosafe® in clinical application.

2021-03-17

CreativeBio has the greatest honor to resonate with ……

It takes tremendous courage and energy to be the trailblazer in cancer screening industry. Under the leadership of Dr Hongzhi Zou , all of us, at the CreativeBio, have taken the responsibility to advocate for early detection of colorectal cancer.

2021-03-09